LDN and Cancer

Poly(ADP-ribose) polymerase inhibitors (PARPis) are an exciting class of cancer drugs currently used in the clinic. To date, however, patients with acute myeloid leukemia--a cancer with a notoriously poor outcome after diagnosis--have failed to respond to them. Scientists have recently shown that combining PARPis with an epigenetic modifier significantly reduces cancer growth and survival of leukemia cells.

Cancer has been a tricky subject for the past many years. Some believe there will never be a cure and some believe we have already found a cure. Some believe cancer is just a part of mother nature doing its job and some believe Big Pharma won't let cancer treatments make it to the mainstream market because it isn't profitable. Either way cancer is not an exact science, how LDN has had a lot of success treating people dealing with cancer. 

Through the work the Dr. Zagon, LDN is capable of suppressing tumor growth. The effects are achieved through direct antagonism of tumor growth or via modifications to the host system. Tumor outmode is a balance of growth and death, and LDN it can alter this balance. There are many anticancer properties in LDN we highly recommend if you have cancer, you start LDN ASAP.